Ongoing treatment(s)-Bone marrow transplant Posts on Medivizor

Posted by Medivizor on Dec 31, 2022 in Leukemia | 0 comments

In a nutshell This study aimed to compare the outcomes of allogeneic hematopoietic cell transplant (alloHCT) for older patients with acute myeloid leukemia (AML) using treosulfan (Trecondi) compared to reduced intensity busulfan (Myleran) conditioning.  This study concluded that treosulfan conditioning appears to be more suitable for...

Posted by Medivizor on Aug 15, 2021 in Leukemia | 0 comments

In a nutshell This study compared the long-term outcomes of umbilical cord (UC) blood transplantation versus unrelated donor transplantation (UD) in patients with acute myeloid leukemia (AML). The data showed that long-term outcomes for patients in complete remission two years after transplantation was not impacted by donor...

Posted by Medivizor on May 30, 2021 in Leukemia | 0 comments

In a nutshell This study aimed to investigate if consolidation chemotherapy before reduced-intensity conditioning (RIC) allogeneic hemopoietic stem cell transplant (alloHSCT) improved outcomes for patients with acute myeloid leukemia (AML).  This study concluded that exposure to consolidation chemotherapy before RIC alloHSCT may help patients...

Posted by Medivizor on Dec 12, 2020 in Leukemia | 0 comments

In a nutshell This study aimed to investigate if the combination of recombinant human granulocyte colony-stimulating factor (rhG-CSF; Filgrastim) and decitabine (Dacogen) would be effective in preventing relapse after transplant for patients with high-risk (HR) acute myeloid leukemia (AML).   This study...

Posted by Medivizor on Aug 23, 2020 in Leukemia | 0 comments

In a nutshell This study aimed to investigate if donor type impacts on the overall outcomes of allogeneic stem cell transplant for children with very high-risk acute lymphoblastic leukemia.   This study concluded that donor type does impact on these patients and that worse outcomes are seen with mismatched donors.   Some...